People can choose to look at this licensing deal as a bad deal if they want. But from ADXS's view, facts are that the company has another $25 million in its pockets, likely another $30 million in milestone payments, and a steady revenue stream in the future from royalty payments for life. And it's all from a small market. Plus this may have woken up some big pharmas to take note, if they want ADXS's products they had better not wait too long. Where's the downside?
Yeah, that's what I was thinking. ADXS will receive royalty payments for sales in Canada. But what does "double digit" mean?
I see that a total of $25 million stock has been sold to those two companies (Knight and Sector Asset Management. In addition the article says:
"Advaxis is eligible to receive double digit royalty as well as sales milestones."
Can anyone elaborate on this? I saw the milestone payment is up to $30 million. But what does double digit royalty mean?
How is it possible that a licensing deal could make the stock price go DOWN? In the red despite a deal which brings in revenue worth almost 10% of the market cap. Meanwhile ADRO is up more than 5% on no news. In what world does that make sense?
Please don't tell me that a licensing deal will lead to a down day for the stock price or only a very small gain. My God, it's a guaranteed $30 million dollars from a small market. This is just a taste of what will eventually come.
Another thing to add, why would Tom Ridge join the Board of Directtors of a POS company? He wouldn't. He must believe ADXS is a solid company.
Yeah, I didn't like the end either. He could have written it better. But he's right in that investors won't flock to ADXS until they have more positive test results released. Until then shorts very well might take this down some more. They're like vultures looking for easy prey. Shorts have wreaked havoc on good companies plenty of times, but eventually the good companies win. I just hope that ADXS mgmt pulls some trick out of their hat with some surprise news, like a deal with Merck or something.
Right, nothing has changed. But unfortunately the article also said there won't be any drug study results til 2016. And seems that is the only thing that will stop shorts from shorting. So I am a bit worried that we may have a few more legs down before the bottom.
That's what I found funny. The stock pops up 75% overnight on a payout and NOBODY can even say how much the payout is. It's totally a #$%$ shoot. And it's now 4 days later and still no one knows. Of course the stock price is falling.
Because, as I see it, ADXS has been approved to raise $200 million and that's all that matters. They see a company, money in hand, that wants to invest a large amount of money in them. ADXS doesn't much care about the stock price as long as they get the money into their coffers.
But the question is about early termination. Early termination of what? Also my question is, if this is important stock moving news then why is it 12 days old?
"I've dedicated over 20 years of work to the application of Listeria monocytogenes in targeted tumor-associated antigens," said Dr. Paterson. "I am thankful for the opportunity to showcase the success of this process in HER2 expressing breast cancers."
From the PR:
The presentation, which is scheduled to take place during the symposium on "Immunotherapy of Breast Cancer," will highlight pre-clinical research findings with Advaxis's Lm Technology(TM) immunotherapy ADXS-HER2
She wouldn't say this if negative news is coming from this meeting. I'm thinking there will be an update with positive news.
This isn't typical profit taking. This stock has broken thru support levels and at one point today was down 50% from its intraday high 6 weeks ago.
Yeah you're right, and I'll be a likely candidate in the future because I'm not gonna go my entire life without kissing.
Well, I hope ADXS hurries up and gets their ADXS-HPV vaccine out to market because I hope to do a lot of kissing before I die. isn't that some $hit? One of the most fun things in life can kill you.
Just giving my opinion on what i see. I'm so use to ADXS moving up and down quickly but lately it just sits near $18 with very little volume. That's what I mean by dead. It isn't moving. Why should I sell out? Because you can't stomach my opinion? lol I'm fully invested and plan to stay that way til we near $30 again.
Feels like this company has lost its excitement. Where are the big investors? Why are there no big investors wanting to buy at $18 when they bought big at $19?